Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05555225

Methylome Study in Sporadic Limb Malformations

Methylome Study in Patients Affected With Sporadic Limb Malformations

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
48 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Some limb malformations are known to be sporadic (non hereditary). For these malformations, no molecular cause was identified, even after whole genome sequencing. Methylation of CpG islands is an epigenetic process which is usually not transmitted to the descents. We hypothesize that sporadic limb malformations may be due to a methylation anomaly. This study will include patients with Amelia or Femur Fibula Ulna Syndrome. With patients consent, we will study the methylome on DNA samples already available in our laboratory. Each patient sample will be paired to a control of same tissue, age and sex. By bioinformatics comparison, we will identify differentially methylated candidate regions.

Conditions

Interventions

TypeNameDescription
OTHERMethylomeEpigenetic study : analysis of DNA methylation

Timeline

Start date
2025-04-01
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2022-09-26
Last updated
2024-05-16

Source: ClinicalTrials.gov record NCT05555225. Inclusion in this directory is not an endorsement.